4basebio (LSE:4BB) Revenue : £0.35 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio Revenue?

4basebio's revenue for the six months ended in Jun. 2023 was £0.24 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2023 was £0.35 Mil. 4basebio's Revenue per Share for the six months ended in Jun. 2023 was £0.02. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.03.

During the past 12 months, the average Revenue per Share Growth Rate of 4basebio was 12.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, 4basebio's highest 3-Year average Revenue per Share Growth Rate was 11.20% per year. The lowest was 11.20% per year. And the median was 11.20% per year.

4basebio Revenue Historical Data

The historical data trend for 4basebio's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Revenue Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Revenue

0.20

0.46

0.34

0.27

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Revenue	Get a 7-Day Free Trial			0.18	0.16	0.15	0.12	0.24

Competitive Comparison of 4basebio's Revenue

For the Biotechnology subindustry, 4basebio's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4basebio's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's Revenue distribution charts can be found below:

* The bar in red indicates where 4basebio's Revenue falls into.

4basebio Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.35 Mil.

4basebio (LSE:4BB) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

4basebio Revenue Related Terms

Thank you for viewing the detailed overview of 4basebio's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (LSE:4BB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

88Q:Germany

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines